However, both TTP and the survival rate of NSCLC patients with BAG-1 positive expression (74 cases) were dramatically increased (TTP, 49.3 months; 5-year survival rate, 16.21%) (χ2=7.243, P=0.007) (Fig. 2B). Here, BAG1 is linked to non-small cell lung carcinoma.